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Hyperacetylation and Gene Activation
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transcription factors. In addition, it has recently been
shown that p300/CBP and PCAF are able to acetylate
nonhistone proteins, including some transcription fac-
tors such as p53 and components of the general tran-
scription machinery such as TFIIE (Gu and Roeder, 1997;
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Imhof et al., 1997). However, the precise role of histone³Graduate Program in Molecular Pathology
acetylation and nonhistone protein acetylation in theUniversity of California at San Diego
process of transcriptional activation in vivo remains un-La Jolla, California 92037
clear.
Nuclear hormone receptors represent a large family
of ligand-dependent transcription factors. They are keySummary
regulators of cell growth and differentiation, homeosta-
sis, and development (reviewed in Mangelsdorf et al.,Nuclear receptors have been postulated to regulate
1995). In the absence of hormone, nuclear receptorsgene expression via their association with histone acet-
repress transcription of target genes via their associa-ylase (HAT) or deacetylase complexes. We report that
tion with corepressor complexes that contain histonehormone induces dramatic hyperacetylation at endog-
deacetylase activity. Hormone binding triggers the re-enous target genes through the HAT activity of p300/
lease of corepressors and the subsequent associationCBP. Unexpectedly, this hyperacetylation is transient
of an array of coactivators (reviewed in Perlmann andand coincides with attenuation of hormone-induced
Evans, 1997; Torchia et al 1998; and see below). Consis-gene activation. In exploring the underlying mecha-
tent with the notion that enzymatic activities may benism, we found that the acetylase ACTR can be acet-
required to counteract the action of histone deacety-ylated by p300/CBP. The acetylation neutralizes the
lases, many of the nuclear receptor coactivators identi-positive charges of two lysine residues adjacent to the
fied, including p300/CBP, PCAF, ACTR, and SRC-1, exhibitcore LXXLL motif and disrupts the association of HAT
HAT activities and acetylate both free and nucleosomalcoactivator complexes with promoter-bound estrogen
histones in vitro (see above for references). However,receptors. These results provide strong in vivo evi-
evidence addressing the role of protein acetylation indence that histone acetylation plays a key role in hor-
hormone-induced gene activation in vivo is entirelymone-induced gene activation and define cofactor
lacking.acetylation as a novel regulatory mechanism in hor-
Among the numerous nuclear receptor coactivatorsmonal signaling.
identified, the p160 family proteins, including SRC-1,
TIF2/GRIP1, and ACTR/AIB1/RAC3/pCIP (see TorchiaIntroduction
et al., 1998 for review), are relatively well characterized.
Several functional domains are conserved among the
Transcriptional activation is a dynamic and complex
p160 family members, including the central receptor
process, involving directed recruitment of coactivator
interaction domain and the carboxy-terminal domains
complexes and assembly of functional transcription ma- responsible for the HAT activity and interaction with
chinery at the target gene promoter. Recent studies p300/CBP and PCAF. Both structural and mutational
have suggested a strong link between histone acetyla- analyses have indicated that multiple LXXLL motifs, lo-
tion, chromatin remodeling, and gene regulation (re- cated in the central region of the coactivators, function
viewed in Grunstein, 1997; Wade and Wolffe, 1997; Ka- as protein±protein interaction modules by directly con-
donaga, 1998; Struhl, 1998; Workman and Kingston, tacting a hydrophobic groove formed on the surface of
1998). In particular, a number of transcriptional regula- receptor ligand-binding domains (LBD) upon binding of
tory proteins, including GCN5 (Brownell et al., 1996; an agonist hormone (Heery et al., 1997; Torchia et al.,
Kuo et al., 1996), PCAF (Yang et al., 1996), p300/CBP 1997; Darimont et al., 1998; Nolte et al., 1998; Shiau et
(Bannister and Kouzarides, 1996; Ogryzko et al., 1996), al., 1998; Voegel et al., 1998). In contrast, antagonist
TAFII250 (Mizzen et al., 1996), and the nuclear hormone ligands such as tamoxifen and raloxifene for estrogen
receptor coactivators ACTR (Chen et al., 1997) and receptor (ER) induce the receptor to assume a confor-
SRC-1 (Spencer et al., 1997), have been found to pos- mation where intramolecular interaction between the
sess intrinsic histone acetyltransferase (HAT) activity. activation function domain 2 (AF2) and the LBD core
Recently, mutation analysis of yeast GCN5 indicates a occludes the coactivator association (Brzozowski et al.,
direct role for the HAT activity in histone acetylation and 1997; Shiau et al., 1998). Amino acids flanking the LXXLL
transcriptional activation of target genes in vivo (Kuo et motif may serve to modulate the specificity and affinity
al., 1998; Wang et al., 1998). These findings suggest a of the coactivator±receptor interactions as evidenced
mechanism whereby the activators recruit HAT com- by the fact that different receptors display preferences
plexes to the promoters of target genes, allowing for for different LXXLL-containing a helices (Darimont et al.,
acetylation of histones to increase the accessibility of 1998; McInerney et al., 1998; Hong et al., 1999).
Functionally distinct nuclear receptor coactivators
have recently been identified, including TIF1, ARA70,§ To whom correspondence should be addressed (e-mail: evans@
PGC1 (reviewed in Torchia et al., 1998), the multisubunitsalk.edu).
‖ These authors contributed equally to this work. complexes TRAP/DRIP (Fondell et al., 1996; Rachez et
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al., 1998; Yuan et al., 1998), and the recently described gene promoter chromatin (Figures 1Aa±1Ad). Changes
in H3 were always less dramatic, but significant increaseRNA molecule SRA (Lanz et al., 1999). TRAP/DRIP com-
in H3 acetylation was also observed at the EB1, c-Myc,plexes have been shown to enhance receptor function
and CTD promoters (Figures 1Ab±1Ad). In contrast, asin an in vitro reconstituted system with general transcrip-
shown in Figures 1Af and 1Ag, no significant acetylationtion factors and naked DNA templates, suggesting that
can be detected when samples from E2-treated MCF-7they act directly on the RNA polymerase II apparatus.
cells were analyzed for RAR target genes CD38 and p21Interestingly, components of TRAPs/DRIPs were also
(Drach et al., 1993; Kontani et al., 1993; Jiang et al.,found recently in other cofactor complexes such as
1994). However, following RA treatment of HL-60 cells,SMCC and CRSP (Ito et al., 1999; Ryu et al., 1999).
strong H4 hyperacetylation is found on both the p21 andStudies of the kinetics of hormone-induced gene ex-
CD38 promoters (Figures 1Ba±1Bd, 4.2- and 7.8-fold,pression have revealed that transcriptional responses
respectively). An increase of acetylation on H3 (4.3-fold)to stimulation by hormones such as estrogen and dexa-
was also detected at the CD38 promoter (Figure 1Bc).methasone are often attenuated after the initial bursting
Consistent with the previous finding that RA repressesactivity (Brown et al., 1984; Sasaki et al., 1984; Cavailles
certain ER target genes (Pratt et al., 1996), treatmentet al., 1988; Dubik and Shiu., 1988). The molecular mech-
of HL-60 cells with RA resulted in decreased level ofanism underlying such kinetics, however, is poorly un-
acetylation on H4 (0.3-fold) at pS2 gene (Figure 1Be).derstood. To better define nuclear receptor±coactivator
These results indicate that the observed change in acet-association and to understand the role of histone acet-
ylation level is restricted to target genes and not aylation in hormonal signaling in vivo, we have examined
nonspecific effect of hormone treatment. An examina-the change of histone acetylation level and the recruit-
tion of upstream flanking sequences 3±4 kb from thement of coactivators at receptor target genes in cells in
CTD (Figure 1Ae) or p21 (Figure 1Bb) revealed that hor-response to hormonal stimulation. We demonstrate that
mone-induced histone hyperacetylation is diminishedhormone treatment of cells causes a rapid and dramatic
(compare 5.7-fold to 1.8-fold on H4 of CTD, Figure 1A;increase of acetylation of histones at the promoter of
4.2-fold to 1.3-fold on H4 of p21, Figure 1B). In agree-receptor target genes, which, surprisingly, is a transient
ment with previous observation that nuclear receptorphenomenon despite the continuous presence of hor-
coactivators with HAT activities interact with multiplemone. In the search of a mechanism for such dynamic
members of the receptor superfamily, we found that chro-hormone-induced histone hyperacetylation and gene
matin histone hyperacetylation can be observed on vita-expression, we found that the p160 coactivators such
min D3 receptor (VDR) target genes such as p21/WAF1as the acetylase ACTR can be acetylated by p300/CBP
(Jiang et al., 1994; Liu et al., 1996) or VDH (Chen andand that such acetylation disrupts receptor±coactivator
DeLuca, 1995; Zou et al., 1997), as shown in Figure 1C,interaction. Thus, our findings indicate the crucial role
and glucocorticoid receptor (GR) target genes (data notof histone acetylation in gene activation and acetylase
shown). Taken together, these data indicate that hor-protein acetylation in transcriptional attenuation.
mone-induced gene expression involves histone hyper-
acetylation of chromatin at hormone response elements
of target genes in vivo.Results
Histone Hyperacetylation Is Both AgonistHormone Treatment Induces Histone Hyperacetylation
and Receptor AF2 Dependenton Chromatin of Endogenous Nuclear
To establish the role of nuclear receptors in mediatingReceptor Target Genes
hyperacetylation, we first investigated the histone acet-To directly assess whether hormone induction of gene
ylation status on ER target genes in MCF-7 cells treatedexpression correlates with changes in the status of his-
with anti-estrogens. As shown in Figure 2A, while E2 istone acetylation, we chose to analyze histone acet-
able to induce histone hyperacetylation on ER target
ylation level at receptor target genes by chromatin im-
gene pS2 (lane 1), no significant change in the histone
munoprecipitation (ChIP) assay. Antibodies specific to
acetylation status is seen when cells are treated with
acetylated histones were used to immunoprecipitate anti-estrogen 4(OH)-tamoxifen or ICI182,780 (lanes 2
formaldehyde-cross-linked, sonicated chromatin from and 3). In agreement with a previous study showing that
cells treated with or without hormones. The resulting pure ER antagonist inhibits E2-induced transactivation
partitioned genomic DNA was then analyzed by quanti- (Hyder et al., 1997), ICI182,780 diminishes E2-induced
tative PCR using primers spanning the hormone re- histone hyperacetylation when cells are treated simulta-
sponse elements for changes in the relative level of DNA neously with the two ligands (lane 4). Similar results
associated with acetylated histones (Braunstein et al., were obtained on c-Myc and CTD (data not shown). We
1993; Rundlett et al., 1998). Several estrogen receptor next examined the histone acetylation status in a cell line
(ER) target genes have been identified in MCF-7 cells derived from HL-60, namely HL-60R, which expresses a
whose expression can be induced by 17b-estrodiol mutant form of RARa with a truncation in AF2 domain
(b-E2), including pS2, cathepsin D (CTD), c-Myc, and EB1 that renders it resistant to RA-induced target gene acti-
(Brown et al., 1984; Cavailles et al., 1988; Dubik and vation and granulocyte differentiation (Robertson et al.,
Shiu, 1988; Watanabe et al., 1998). As shown in Figure 1992). As shown in Figure 2B, treatment of HL-60R cells
1A, ChIP analysis with antibodies to acetylated H3 (at with RA fails to induce histone hyperacetylation at target
both lysine 9 and 14) and to acetylated H4 (at the N genes p21 and CD38 (lane 2). However, when HL-60R
terminus of all four lysines) revealed that indeed E2 treat- cells are treated with histone deacetylase inhibitor TSA,
ment of MCF-7 cells causes remarkable increase (5- to significant increase in histone acetylation can be ob-
served (lane 3), consistent with our previous results that8-fold) in the acetylation level on H4 at all four target
Histone and Cofactor Acetylation
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Figure 1. Induced Histone Hyperacetylation
at Nuclear Receptor Target Genes
(Left columns) Schematic representation of
ER and RAR target gene promoter regions
with identified cognate hormone response el-
ements indicated by arrows. Note that the
ERE identified on EB1 gene is localized at the
first intron. Bars and the numbers below each
target gene represent the relative positions
in the genes and the length that are amplified
in the PCR analysis.
(Middle columns) Soluble chromatin prepara-
tions from cell cultures treated with (1) or
without (2) indicated hormones were immu-
noprecipitated with the antibodies against
acetylated histone H3 (a-AcH3) or H4 (a-AcH4)
and analyzed by quantitative PCR. Aliquots
of the chromatin were also analyzed before
immunoprecipitation (INPUT).
(Right columns) Relative histone acetylation
levels (fold of acetylation) are determined by
quantitation of PCR product using NIH Image
software and by correction with the input data
and represented as ratios of relative acetyla-
tion of H3 or H4 in the presence versus the
absence of hormone treatment. Similar re-
sults were obtained in at least three experi-
ments.
(A) Estrogen induces histone hyperacetyla-
tion at ER target genes pS2, EB1, c-Myc, and
CTD. MCF-7 cells were treated with 1027 M
17 b-estrodiol (E2) for 2 hr before harvested
for chromatin immunoprecipitation.
(B) Retinoic acid treatment (1027 M for 2 hr)
of HL-60 cells induces histone hyperacetyla-
tion at the RAR target genes p21 and CD38.
(C) 1,25-(OH)2-D3 (5 3 1028 M for 2 hr) in-
duces histone hyperacetylation on target
genes p21 and VDH in HL-60 cells.
TSA potentiates retinoic acid±induced cell differentia- Hanstein et al., 1996; Kamei et al., 1996; Yao et al., 1996;
Kraus and Kadonaga, 1998). Using immunoprecipitationtion (Nagy et al., 1997; Lin et al., 1998). Taken together,
these results indicate that hormone-induced histone assays, we found that endogenous ER associates with
a variety of coactivator proteins, including p300/CBPhyperacetylation is receptor dependent and requires the
integrity of the AF2 domain. as well as ACTR, Brg1, and BAF155, in a hormone-
dependent manner (Figure 3A, lanes 9 and 10). Since
the HAT activity of p300 and CBP has been relativelyp300/CBP HAT Activity Is Critical
The two closely related transcriptional coactivtors p300 well defined, we examined whether it is required for
hormone-induced histone acetylation. To this end, MCF-7and CBP have been demonstrated to be involved in
nuclear receptor activation (Chakravarti et al., 1996; cells were infected with recombinant adenoviruses
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markedly inhibits E2-induced histone H4 hyperacetyla-
tion on all the ER target genes analyzed (compare lanes
2 and 3 in Figure 3B and data not shown). To further
investigate the role of p300/CBP HAT activity in hormone
signaling, we tested whether HAT activity of p300/CBP
is important for nuclear receptor-mediated gene activa-
tion in transient transfection assay. Consistent with pre-
vious results, wild-type CBP or p300 enhances both
RAR and ER transactivation in the presence of hormones
(Figure 3C, compare lanes 2 and 4 with lane 1). In con-
trast, HAT2 mutants of either CBP or p300 fail to stimu-
late or inhibit slightly the transactivation function of the
receptors (compare lanes 3 and 5 with lane 1). Together
the results of the first three figures strongly support the
proposal that nucleosomal histones are in vivo sub-Figure 2. Hyperacetylation Is Both Agonist and AF2 Dependent
strates of p300/CBP HAT and hormone-induced histone(A) Anti-estrogens are unable to induce histone hyperacetylation on
hyperacetylation and transactivation is largely depen-ER target genes in MCF-7 cells. Chromatin preparations made from
cells treated for 1 hr with 1027 M E2 (lane 1), 4-(OH) tamoxifen (lane dent on the HAT function of p300/CBP.
2), ICI182,780 (lane 3), or both E2 and ICI182,780 (lane 4) were
analyzed for histone H3 and H4 acetylation on target gene pS2 as
described in Figure 1. Dynamic Histone Acetylation and Coactivator
(B) The integrity of AF2 is important for nuclear receptor-mediated Recruitment Induced by Hormone
histone hyperacetylation. Chromatin preparations from HL-60 or HL-
Having established that histone hyperacetylation is re-60R cells treated for 2 hr with 1027 M all-trans retinoic acid (RA,
ceptor dependent, we sought to investigate the timelanes 1 and 2) or 100 nM TSA (lane 3) were analyzed for histone H4
acetylation on RAR target genes p21 and CD38 as described in course of acetylation following hormone activation. Re-
Figure 1. sults shown in Figure 4A indicate that within minutes
after E2 treatment of MCF-7 cells, an increase in tar-
geted acetylation can be observed; within an hour, maxi-
mal acetylation level is achieved, suggesting that the(which are devoid of viral E1 and E3 genes) for expres-
sion of wild-type or HAT2 mutant p300 (delta 1603±1653) effects on pS2 and CTD chromatin are immediate and
robust. Unexpectedly, however, when acetylation wasand then analyzed for E2-induced histone acetylation.
As shown in Figure 3B, expression of wild-type p300 analyzed from cells treated with E2 or RA for longer
times (.1 hr), we found that the maximal levels on bothin MCF-7 cells slightly enhances E2-induced histone
hyperacetylation on target genes when compared with ER and RAR target genes actually declined, becoming
only marginally elevated around 6 hr after hormone in-cells mock-infected (compare lanes 1 and 2), probably
due to the high level of endogenous p300/CBP (see duction and accompanied by the shift of target DNA to
the nonacetylated chromatin pool (Figure 4A and dataFigure 4D). In contrast, expression of HAT2 mutant p300
Figure 3. p300/CBP HAT Activity Is Critical
for Hormone-Induced Histone Hyperacetyla-
tion and Transcriptional Activation
(A) E2-dependent association of ER with re-
ceptor transcriptional cofactors ACTR, p300,
Brg1, and BAF155. Cell extracts made from
MCF-7 cells treated with (1) or without (2)
1026 M b-E2 were immunoprecipitated (IP)
with antibodies indicated, and precipitated
complexes were immunobloted with anti-
ERa antibody.
(B) The HAT activity of p300 is critical for hor-
mone-induced histone hyperacetylation on
ER target genes. MCF-7 cells were infected
with recombinant adenoviruses for expres-
sion of wild-type p300 (lane 2), HAT defective
mutant p300 (lane 3), or GFP (lane 1) and
treated with E2 for 1 hr before histone H4
acetylation on target genes pS2 and CTD was
analyzed as in Figure 1.
(C) The HAT activity of p300/CBP is important
for receptor-mediated transactivation. CV1
cells were transiently transfected with wild-
type or HAT defective mutant p300 or CBP,
along with receptor and reporter constructs
as indicated, treated with either 1028 M b-E2
(a) or 1027 M at-RA (b), and assayed for lucif-
erase reporter activity.
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Figure 4. Hormone-Induced Gene Expression and Histone Acetylation Are Transient
(A) Transient histone hyperacetylation on receptor target genes induced by E2. MCF-7 cells were treated with E2 at 1027 M for different times
as indicated or with hormone solvent for 2 hr as control (C) before harvested for histone H4 acetylation analysis on target genes pS2 and
CTD as in Figure 1A.
(B) Hormone-induced upregulation of target gene expression is attenuated after the initial induction. MCF-7 cells were treated with b-E2 at
1027 M for indicated times before they were harvested for analysis of gene expression by Northern blotting.
(C) Transient engagement of RNA polymerase II onto ER target genes CTD and c-Myc. Chromatin preparations made from MCF-7 cells treated
with b-E2 for indicated times were immunoprecipitated with anti-PolII antibodies. The precipitates were analyzed with PCR for PolII-associated
template DNA at CTD and c-Myc.
(D) E2 treatment of MCF-7 cells does not result in significant alteration of the levels of ER and receptor cofactors. Nuclear extracts made
from MCF-7 cells treated with 1027 M E2 for indicated times were blotted with antibodies specifically to ERa and different receptor cofactors.
(E) Transient association of receptor coactivator ACTR, p300, and CBP with ER target gene promoter. Chromatin preparations made from
MCF-7 cells treated with E2 for indicated times were immunoprecipitated with antibodies to ER, ACTR, p300, and CBP. The precipitates were
analyzed for associated pS2 promoter DNA fragment as indicated in the schematic.
not shown). To examine whether hyperacetylation kinet- rapidly attenuated. These data are also very similar to
previous results obtained by nuclear run-on assays ofics are reflected at the level of gene expression, we
examined accumulation of mRNA at different times after ER target genes (Cavailles et al., 1988; Dubik and Shiu,
1988).E2 treatment of MCF-7 cells. As seen in Northern blot
analysis (Figure 4B), between 1±3 hr after hormone addi- To investigate the molecular mechanism(s) underlying
the observed attenuation of hormone-induced histonetion, E2-induced gene expression declined rapidly and,
in the case of c-Myc, returned to near basal levels, which hyperacetylation and gene activation, we first examined
whether continuous exposure of cells to hormone af-is consistent with previous reports (Cavailles et al., 1988;
Dubik and Shiu, 1988). Therefore, hormone-induced fects the expression of nuclear receptors or their cofac-
tors. Western blotting showed no significant change ofgene expression is rapidly attenuated after the initial
induction, a pattern that coincides well with the transient protein levels after 1 day E2 treatment of MCF-7 cells
for ERs (a and b), ACTR, p300, CBP, PCAF, as well ashyperacetylation patterns described above. To identify
at which level the attenuation occurs, we examined the histone deacetylases and Brg1 (Figure 4D and data not
shown). We then examined the pattern of coactivatorengagement of RNA polymerase II at the target genes
using a procedure similar to ChIP but with antibodies recruitment to the receptor target gene promoter in re-
sponse to hormone using a ChIP-like procedure but withspecific to RNA polymerase II (see Experimental Proce-
dures for details). As shown in Figure 4C, shortly after antibodies specific to individual coactivators. As shown
in Figure 4E, 1 hr exposure of cells to E2 induces thehormone treatment, the association of RNA polII with
target gene template DNA is dramatically increased, association of ACTR as well as p300 and CBP to the
ER target gene pS2 promoter, in accord with the histonereaching the maximum at about 1 hr. However, as de-
scribed above after this rise, RNA polII engagement is hyperacetylation induced by hormone. Surprisingly, longer
Cell
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Figure 5. Acetylation of ACTR by p300/CBP
(A) (a) In vitro acetylation of ACTR and TIF2 by p300 but not PCAF. Purified ACTR (full-length, 200 ng, lanes 2 and 7), TIF2 (aa 486±1464, 100
ng, lanes 3 and 8), p53 (500 ng, lanes 4 and 9), and RIP140 (full-length, 300 ng, lane 5) were incubated with p300 (full-length, 50 ng, lanes 1
to 5) or PCAF (full-length, 200 ng, lanes 6 to 9) in the presence of [14C]-acetyl-CoA at 308C for 1 hr. The acetylation reactions were then
separated by SDS±PAGE and visualized by autoradiography. The trans-acetylated ACTR, TIF2, and p53 as well as autoacetylated p300 and
PCAF are indicated by arrows. (b) Acetylation substrate proteins were separated by SDS±PAGE and stained with Coomassie blue.
(B) ACTR is acetylated in vivo. MCF-7 cells were labeled in the presence of [3H] acetate and the presence (lane 3) or absence (lanes 1 and 2)
of 1026 M b-E2 for 2 hr. Cell extracts were then subject to immunoprecipitation by anti-Flag M2 Ab as control (lane 1) or anti-ACTR-specific
Ab (lanes 2 and 3). The immunoprecipitates were analyzed by SDS±PAGE and autoradiography. The position of [3H]-labeled endogenous ACTR
protein is indicated by an arrow. Asterisk indicates a nonspecific protein. As controls, anti-AcH3 or Ac-H4 antibodies do not immunoprecipitate
endogenous ACTR protein (data not shown).
(C) ACTR is acetylated in the receptor interaction domain (RID). (a) shows the schematics of ACTR functional domains and protein fragments
used in the acetylation reactions. (b and d) GST fusions of ACTR proteins (aa 493±1412 [100 ng], aa 493±1018 [200 ng], and aa 756±1027 [1
mg]), or ACTR proteins with GST portion cleaved (aa 621±821 [400 ng] and aa 621±728 [300 ng]) were acetylated in vitro by p300 and analyzed
as in (A). (c) and (e) show the substrate proteins stained by Coomassie blue.
(D) Identification of acetylation sites in ACTR. (a) Wild-type or mutant ACTR proteins (aa 621±728) were acetylated by p300 in vitro and analyzed
as in (A). About 500 ng of wild-type and mutant K626Q protein was used (lanes 1 and 2). For all the other mutants (lanes 3 to 14), 500 ng and
1.5 mg proteins were tested for acetylation. (b) A synthetic peptide (3 mg) with sequences of aa 621±640 of ACTR was incubated with p300
(300 ng) protein as in (A). After purification, 50% of acetylated peptides was subject to sequencing. Radioactivity was measured for each
cycle by scintilation counting. Arrows indicate the lysine residues acetylated by p300.
E2 exposure (6 hr) diminishes the association of ACTR, idea that the association could be influenced by the
enzymes that are accumulating in activation complexp300, and CBP to chromatin without affecting the bind-
ing of ER to its target promoter. These results suggest itself. This speculation is reasonable, since HATs such
as p300/CBP and PCAF are also able to acetylate non-that hormone-induced recruitment of coactivators to a
receptor target gene is not constitutive and mechanisms histone proteins, including p53, TFIIE, HMG, and EKLF,
to modulate their activities, such as interaction with DNAexist to terminate the association of HAT proteins de-
spite the continued presence of ligand. (Gu and Roeder, 1997; Imhof et al., 1997; Munshi et al.,
1998). We thus asked whether ACTR can be acetylated
by its associated HATs p300/CBP and PCAF. As shownAcetylation of ACTR by p300/CBP
In the search for a mechanism(s) regulating the recep- in Figure 5A, indeed, purified recombinant ACTR and its
family members TIF2 and SRC-1 (lanes 2 and 3 of [a]tor±coactivator association, we were prompted by the
Histone and Cofactor Acetylation
681
and data not shown) can be efficiently acetylated by of K629 and K630, a peptide bearing acetyl groups on
these residues was synthesized and tested in a competi-p300 in vitro, while RIP140 (lane 5), another cofactor
potentially involved in nuclear receptor function, is not tion experiment. GST pull-down assays were employed
to assess the ability of the acetylated peptide to com-acetylated under the same conditions. Although PCAF
strongly acetylates itself and p53 (lane 9), it fails to signif- pete with in vitro translated receptors for binding to
GST-RID in the presence of hormones. As shown inicantly acetylate ACTR or TIF2 (lanes 7 and 8), indicating
that ACTR and its family members are substrates for Figure 6B, while the unmodified peptide competes
strongly with ER (about 50% at 5 mM, lane 6), the doublep300 but not PCAF. To determine whether ACTR is also
acetylated in vivo, MCF-7 cells were labeled with acetylated peptide is unable to efficiently compete off
ER even at the highest concentration (about 10% at 200[3H]acetate, and ACTR protein was then immunoprecipi-
tated with ACTR-specific antibody. As shown in Figure mM, lanes 8 to 11). Similar results were obtained with
other receptors, including RAR (data not shown). Since5B, the endogenous ACTR proteins can be specifically
labeled by [3H]acetate, indicating that ACTR is indeed ACTR-RID has three LXXLL motifs that are potentially
important for receptor association, we sought to deter-acetylated in vivo. Importantly, a significant increase in
levels of acetylated ACTR can be detected when cells mine the contribution of each of the motifs to receptor
binding. Accordingly, ªLLº in each motif is mutated toare treated with E2 for 2 hr (compare lanes 2 and 3),
reaching the highest around 3 hr after E2 treatment (data ªAAº either singly or in combination, and the resulting
RIDs were tested for interaction with ER in a mammaliannot shown), suggesting that hormone-induced recruit-
ment of an ACTR/p300/CBP complex triggers the acet- two-hybrid assay. As shown in Figure 6C, while disrup-
tion of the third motif (M32) does not significantly alterylation of ACTR.
To gain insight into the functional relevance of this the interaction of ACTR with ER, disruption of the first
motif, either alone (M12) or in combination with muta-acetylation, we first mapped the region of ACTR modi-
fied by p300 in vitro. As shown in Figure 5C, ACTR tions in the other two motifs (M1122 and M1132), re-
sulted in virtually complete loss of ER binding activity.proteins lacking amino- or carboxy-terminal domains
can still be efficiently acetylated (lanes 2 and 3 of [b]), These data indicate that M1 is required for ACTR±ER
interaction. Thus, acetylation of the lysines in M1 wouldwhile a deletion within the receptor interaction domain
(RID) results in a substantial decrease (lane 4). In fact, not only disrupt its interaction with receptors but cripple
the function of the whole RID. Together, these resultsas shown in Figure 5Cd, both the whole RID containing
aa 621±821 as well as the amino-terminal half containing suggest that p300/CBP recruited by liganded receptors
not only acetylates histones at target response elementsaa 621±728 (N-RID) can be acetylated. To identify the
residues of ACTR acetylated by p300, we mutated all but also acetylates ACTR, which leads to the dissocia-
tion of ACTR from receptors.the lysines within N-RID to glutamine and tested for
acetylation by p300. Results in Figure 5Da clearly indi- To investigate the in vivo consequences of ACTR acet-
ylation, we transfected CV1 cells with plasmids express-cate that change of K629/630 to Q (lanes 3 and 4) se-
verely reduces the acetylation, while mutation of K626 ing wild-type ACTR or mutants in which the two lysines
(K629 and K630) were substituted with nonacetylableto Q (lane 2) also affects acetylation but to a lesser
extent. These results identify the three lysine residues arginines (KK-RR) or glutamines (KK-QQ). Cotrans-
fected reporter activity was measured at different timesthat are immediately proximal to the first LXXLL motif
as presumptive acetylation sites. To verify these results, after transfection. Results shown in Figure 6D indicate
that ACTR potentiation of ER transactivation declineda synthetic peptide containing the first receptor interac-
tion helical motif (aa 621±640) was incubated with p300 3 days after transfection, consistent with our results on
the target gene expression pattern described in Figuresand [14C]-acetyl-CoA. The acetylated peptide was sub-
jected to amino-terminal sequencing (Figure 5D). These 4B and 4C. However, no significant decrease of activity
is observed for the two mutant forms of ACTR (KK-results confirm the mutagenesis analysis and indicate that
lysines K629 and K630 are the preferred acetylation sites RR and KK-QQ) even 3.5 days after transfection. These
results suggest that ACTR acetylation downregulatesand lysine 626 can also be acetylated to a lower level.
nuclear receptor-mediated transactivation.
Acetylation of ACTR by p300 Disrupts the Association
of ACTR with Receptors The Structural Basis of Acetylation-Induced Disruption
of ACTR±ER InteractionThe fact that acetylated sites identified on ACTR are
adjacent to the LXXLL motif prompted us to investigate To understand at the structural level how acetylation of
ACTR affects its interaction with receptors, we exam-the consequence of acetylation on the ability of ACTR to
bind nuclear receptors. As demonstrated previously (Chen ined the previously determined cocrystal structure of
the ERa LBD with an LXXLL motif from GRIP1 (Shiau etet al., 1997), association of ACTR-RID with liganded
receptors results in the formation of complexes that al., 1998). This and other structural studies have indi-
cated a conserved mechanism of coactivator recogni-migrate more slowly than the receptor±DNA complexes
in a gel mobility shift assay (Figure 6A, lane 2). Interest- tion whereby the hydrophobic surface formed by the
conserved leucine residues of the LXXLL amphipathicingly, acetylation by p300 (full-length or carboxy-termi-
nal half, aa 1135±2414) reverses the supershifting to an a helix packs into a hydrophobic groove composed pri-
marily of conserved residues in helices H3, H4, H5, andER-only complex (lanes 4 and 6). As shown in lanes 3
and 5, p300 itself does not affect the association of H12 of the receptor LBDs. This interaction is stabilized
by two highly conserved charged residues (Glu and Lys)ACTR with receptor. These results clearly indicate that
ACTR acetylation destabilizes receptor association. To on the LBD, which ªcapsº the LXXLL helix in place (Dari-
mont et al., 1998; Nolte et al., 1998; Shiau et al., 1998).prove that disruption of the complex is due to acetylation
Cell
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Figure 6. Acetylation of ACTR by p300 Disrupts ACTR±Receptor Complex
(A) ACTR receptor±interaction domain (RID) protein was incubated with either full-length (lanes 5 and 6) or C-terminal fragment (aa 1135±2414,
lanes 3 and 4) of p300 proteins in the presence (lanes 4 and 6) or the absence (lanes 3 and 5) of acetyl-CoA before mixing with purified human
ERa protein, 1026 M b-E2, and [32P]-ERE oligonucleotides for gel shift assay. The positions of ER homodimer and ER±ACTR RID ternary
complexes were indicated by arrows. The free DNA probe is omitted. Note that direct association of p300 with ERa cannot be detected under
this condition.
(B) An acetylated receptor interaction motif does not associate with agonist-bound ER complex. GST±RID (aa 621±728) was incubated with
labeled ERa in the presence of 1026 M b-E2 and the absence (lane 3) or presence of increasing concentration (5, 20, 50, and 200 mM) of wild-
type ACTR receptor interaction motif 1 (aa 621±640, lanes 4 to 7) or aa 629/30 acetylated motif 1 (lanes 8 to 11). ER protein specifically bound
to the RID was resolved by SDS±PAGE and visualized by autoradiography.
(C) The first receptor interaction LXXLL motif is the major determinant for ACTR±ER interaction. CV1 cells were transfected with GAL4 fusions
of wild-type or mutant ACTR RID, together with VP16-AD-ER-LBD and reporter constructs as indicated, treated with 1027 M E2, and assayed
for reporter luciferase activity. The relative interaction strength between E2-bound ER-LBD and ACTR is measured as fold of reporter gene
activation in the presence of E2.
(D) Attenuation of the potentiation of ER transactivation function by wild-type but not the nonacetylable mutant ACTR. CV1 cells were
transfected with wild-type or mutant ACTR constructs where the two acetylated lysines (K629 and K630) are changed to nonacetylable
arginines (KK-QQ) or glutamines (KK-RR), together with expression vector of ER and reporter luciferase. E2-induced reporter gene activity
shown as fold of activation is measured at different times after transfection. It should be noted that the relative long time sustaining of high
reporter activity is likely due to the high stability of luciferase.
The helical structure and hydrophobic interface of the hydrophobic groove on the ER LBD. Acetylation at the
e-NH31 group of K629 and K630 in ACTR would abrogateLXXLL motif in the cocrystal structure were adopted for
ACTR with a single amino acid substitution (HKILXXLL those electrostatic interactions, with the consequence
of eliminating a key stabilizing interface. Such a dramaticin GRIP1 to HKKLXXLL [aa 628±635] in ACTR). Remark-
ably, the amino group of Lys-629 of ACTR is found in increase in free energy provides a probable structural
basis for the switching effect associated with ACTR-close proximity (within 2.6±3.0 AÊ ) to Glu-380 of the ERa
LBD, rendering it fully capable of making electrostatic RID acetylation.
contact with the carboxyl group of Glu-380 from H5 in
ER (Figure 7). Similarly, the amino group of Lys-630 of Discussion
ACTR is predicted to contact the side chain of Asp-538
from H12 of ERa. Therefore, the association of ACTR Recent findings that nuclear proteins associated with
liganded nuclear receptors possess histone acetyltrans-with ER is likely to be determined by two different inter-
faces, one that is mainly hydrophobic and conserved ferase activity has strengthened the link between his-
tone acetylation and hormone-induced gene activation;in all the LXXLL helix-receptor-LBD interactions, and a
second that is characterized by electrostatic interac- however, crucial evidence has been lacking to demon-
strate histone acetylation as a key mechanism in recep-tions formed between the lysines N-terminal to the first
LXXLL motif and the charged residues at the rim of the tor-mediated transctiptional activation. We report here
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the target genes are shut off has been poorly under-
stood.
In our attempt to examine the role of individual coacti-
vators in hormone signaling, we found that p300/CBP
HAT is particularly critical for hormone-induced hyper-
acetylation of H3 and H4 as well as activation of receptor
target genes. These results are consistent with the re-
cent study that the HAT activity of p300/CBP is required
for efficient chromatin dependent in vitro transcription
by ER (W. L. Kraus and J. Kadonaga, personal communi-
cation). Using anti-acetylated lysine-specific antibodies,
we found that lysines 5 and 8 of H4 are the primary in
vivo hyperacetylated sites (data not shown), which is
consistent with the in vitro histone acetylation patterns
of p300/CBP (Bannister and Kouzarides., 1996; Ogryzko
et al., 1996; Schiltz et al., 1999). On the other hand, both
recombinant PCAF (Yang et al., 1996) and purified PCAF
histone acetylase complex (Ogryzko et al., 1998; Schiltz
et al., 1999) preferentially acetylate histone H3, therefore
making PCAF less likely to be the key coactivator in
hormone-induced histone acetylation. This raises theFigure 7. Structural Basis of Acetylation-Induced Disruption of
issue as to the role of each of the HAT subtypes in theACTR±ER Interaction
activation complex and suggests that the acetyltransfer-The cocrystal structure of ERa LBD with the LXXLL motif 2 from
ase activities of PCAF and the p160 coactivators suchGRIP1 (Shiau et al., 1998) was examined using the data for the
monomer B of ER and its associated ligand and GRIP1 peptide. The as ACTR and SRC-1 may act on other protein targets
helical structure and hydrophobic interface of the LXXLL motif in or play different roles at different target genes.
the cocrystal structure were adopted for ACTR with a single amino
acid substitution that Ile-689 in GRIP1 is changed to Lys-630 in
Cofactor Acetylation as a Regulatory MechanismACTR. The coactivator peptide and part of the ERa LBD are shown
in Hormonal Signalingas ribbon drawings with ACTR motif 1 in green and receptor LBD
in gold. The agonist ligand DES is shown in space-filling representa- Nuclear receptor-mediated gene expression has gener-
tion. The electrostatic interactions between the e-amino group of ally been perceived as a steady-state process where
Lys-629 and Lys-630 of ACTR and the carboxyl group of Glu-380 hormone acts as a switch to turn on the transcription
and Asp-538 are illustrated as dashed orange bonds. The unstruc-
of target genes and thereafter maximal activation wouldtured loop between helix 9 and 10 is depicted as a dashed line.
persist as long as the cognate hormone is present. How-
ever, in examining the link between activation and chro-that both steroid hormones and vitamins A and D are
matin remodeling, we found that hormone-induced his-able to induce hyperacetylation of histones at the pro-
tone hyperacetylation is a transient event that peaksmoters of target genes in vivo. We provide evidence
within an hour of hormone induction and is stronglythat hyperacetylation is mediated by receptors and their
downregulated thereafter. We found that the expressionassociated coactivators. Surprisingly, we find that the
of ER target genes, including c-Myc, CTD, and pS2, ashormone-induced histone acetylation is a dynamic pro-
judged by Northern analysis and RNA polII engagement,cess and can be attenuated by acetylation of the acet-
is significantly attenuated after the initial induction. Im-ylase.
portantly, the expression kinetics match the profile of
histone hyperacetylation, therefore supporting our con-Role of Histone Acetylation in Nuclear Receptor-
clusion that histone acetylation (and deacetylation)Mediated Gene Regulation
plays a critical role in hormone induction of gene expres-Previous results from the characterization of nuclear
sion. Most surprisingly, the trigger that attenuates thereceptor coactivators indicate that the p160 coactiva-
activation is in fact the same HAT (p300/CBP) that stimu-tors and p300/CBP interact with virtually all the recep-
lates the process. Thus, upon hormone binding, nucleartors in a hormone-dependent manner, suggesting a
receptors recruit the p160 coactivators and p300/CBPcommon pathway of hormone-induced gene activation.
to the target gene. The acetyltransferase activity ofConsistent with this notion, we find that in vivo histone
p300/CBP will acetylate histones to remodel chromatinacetylation levels of ER, GR, RAR, and VDR target genes
and also begin to modify other target proteins suchare all significantly increased upon hormone induction.
as the p160 coactivators. This latter acetylation eventIn addition, hyperacetylation of histones is triggered by
results in the disruption of p160 coactivator±receptorantagonists and requires an intact AF2 domain. Thus,
interaction, which in turn leads to the dissociation ofour results further define chromatin histone acetylation
coactivator complex including p300/CBP from receptoras a critical step in nuclear receptor-mediated hormonal
and the target gene promoter. Several lines of evidencesignaling. Based on our analysis of a number of receptor
support this model of autoregulation of hormone induc-target genes by multiple hormones, it is reasonable to
tion. First, the acetylation of endogenous ACTR proteinspeculate that histone hyperacetylation is a common
is significantly enhanced by hormone treatment of cells,underlying feature to receptor-mediated activation. In-
suggesting that recruitment of the coactivator complextrinsic to any physiological process is a need to attenu-
ate the response. Nonetheless, the mechanism by which also stimulates the acetylation of ACTR. Second, our
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108 cells were fixed with formaldehyde (1% final concentration) atresults from both in vitro acetylation gel shift and peptide
room temperature for 10 min. Soluble chromatin was made as de-competition experiments clearly indicate that acetyla-
scribed (Braunstein et al., 1993) and subject to immunoprecipitationtion of ACTR by p300 results in destablization of recep-
in lysis buffer (25 mM Tris [pH 8.1], 140 mM NaCl, 1% Triton X-100,
tor±coactivator interaction. Third, the kinetics of ACTR 0.1% SDS, 3 mM EDTA, and 13 protease inhibitor cocktail [Boeh-
recruitment to receptor target gene promoter appears ringer Mannheim]) with 8 ml of anti-acetylated H3 antisera or 5 ml
of anti-acetylated H4 antibody (from Upstate Biotech and Serotech)to be very similar to that of hormone-induced histone
at 48C overnight. Sonicated salmon sperm DNA (5 mg) was mixedhyperacetylation. Although we have focused our investiga-
with the chromatin solution briefly. Immunocomplexes were thention on the effect of ACTR acetylation on its receptor
recovered by adding 50 ml of 50% protein A-Sepharose beads sus-interaction, the acetylation of other p160 coactivators, in-
pension and incubated at 48C for 2 hr. Beads were washed sequen-
cluding TIF2 and SRC-1, as demonstrated here, may also tially for 5 min each in 10 ml of TSE buffers with 150 and 500 mM
affect their interaction with receptors in a similar manner. NaCl, buffer III, and TE (pH 8) as described previously (Braunstein
et al., 1993). Immunocomplexes were eluted off the beads by incuba-The fact that hormone-induced histone hyperacetyla-
tion with 200 ml of 1% SDS, 0.1 M NaHCO3. The elution was heatedtion can be a transient and regulated event illustrates
at 658C for 6 hr to reverse the formaldehyde cross-links and phe-the dynamic nature of the transcriptional process, which
nol:chloroform extracted. Ethanol-precipitated DNA was resus-is a consequence of numerous protein±protein and pro-
pended in 50 ml TE. Quantitative PCR was performed with 10 ml of
tein±DNA interactions. Based on these results, it can be the DNA sample and 22 to 25 cycles. PCR products were resolved
envisaged that acetylation and/or phosphorylation of and visualized with ethidium bromide. Images were recorded and
quantified using NIH Image 1.5 software. For chromatin immunopre-cofactors or other proteins involved in the activation
cipitation with antibodies to ERa, p300, CBP, Pol II (Santa Cruzprocess could create sequential cycles of association and
Biotech), ACTR (aa 756±1027, see above), and Brg1 (a generous giftdissociation of cofactor complexes. For instance, the
from Dr. Gerald Crabtree), purified chromatin was prepared fromhistone and cofactor acetylation activity of the p160/
approximately 2 3 108 MCF-7 cells and immunoprecipitated with 2
p300/CBP/PCAF initiated by hormone could pave the to 6 ml of the antibodies as described (Orlando et al., 1997) and
way for other factors such as the TRAP/DRIP complex precipitates analyzed as above.
to enhance transcriptional initiation. These replacement
activities could both promote and paradoxically attenu- In Vivo 3H Labeling and Anti-ACTR IP
Approximately 107 MCF-7 cells were resuspended in 5 ml of DMEMate the activation process. In this sense, chromatin re-
containing 10% FBS, 1 mCi/ml [3H] acetic acid (ICN), and 10 mMmodeling complexes, like the p300/CBP and their asso-
sodium butyrate with or without 1 mM of b-E2 and incubated at 378Cciated factors, could play a dual role in control of gene
for 2 hr. Cells were then lysed in RIPA buffer (50 mM Tris [pH 7.5],
expression. 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholine, 0.1% SDS, 1
While attenuation of an inducible response is a com- mM EDTA, and protease inhibitors). Whole cell lysates were immu-
noprecipitated with either anti-Flag (D8, Santa Cruz) or anti-ACTRmon feature inherent to many physiologic pathways,
(aa 756±1027) antibodies at 48C overnight. Immunoprecipitates werehow this is achieved is often poorly understood. In the
subjected to SDS±PAGE. Gels were exposed to X-ray films at 2808Ccase of nuclear receptors, we reveal one mechanism
for 6±8 days.in which activators may serve as targets of their own
enzymatic activities. Thus, acetylation of an acetylase
Acetyltransferase Assays and Identification of ACTR
at precisely the location required for its recruitment pro- Acetylation Sites
vides a remarkable example of a built-in self-regulating Acetyltransferase assays were performed essentially as described
(Ogryzko et al., 1996; Gu and Roeder, 1997). Usually, reactions weremacromolecular system, which may serve as a general
made in 30 ml volume containing 50 mM Tris (pH 8.0), 10% glycerol,paradigm for a self-attenuating transcriptional response.
1 mM DTT, 1 mM PMSF, 10 mM sodium butyrate, 0.5 to 1 ml of [14C]
acetyl-CoA (50 mCi/ml, Amersham), total of 0.1 to 1.5 mg of proteinExperimental Procedures
substrates and 0.05 mg p300 or 0.2 mg PCAF HAT proteins as indi-
cated in the figures, and incubated at 308C for 1 hr. Reaction mix-Plasmids, Proteins, Viruses, Antibodies, and Transfections
tures were analyzed by SDS±PAGE and autoradiography. SyntheticACTR, p300, and CBP in pCMX-PL2 or in pGEX-KG was mutagen-
peptides corresponding to aa 621±640 of ACTR were purified toized using the Quickchange kit (Strategene) and sequenced to con-
95% purity. Approximately 3 mg of the peptide was used in thefirm the mutations. p300 (full-length and aa 1135±2414), RIP140
acetyltransferase reaction as above. Acetylated peptides were puri-(Chen et al., 1997), and TIF2 cDNA (aa 486±1464, amplified from a
fied by HPLC, and 50% of the purified peptide was subjected tohuman cDNA library) was inserted to pAcSG2 with Flag sequences
N-terminal microsequencing. Radioactivity was measured for eachtagged to the amino termini. Recombinant proteins were expressed
cycle by scintillation counting.in Sf9 cells via the baculovirus system (PharMingen) and purified
through Flag-M2 affinity column, or expressed in E. coli and purified
Coimmunoprecipitationas described previously (Chen et al., 1997). p300 wild-type and HAT
Approximately 5 3 106 MCF-7 cells cultured either in the presencedefective mutant (delta aa 1603±1653) was subcloned to adenovirus
or absence of b-E2 (1 mM) for 24 hr were collected in IP buffer (13transfer vector pAd-Track-CMV. The resulting construct was used
PBS, 0.1% NP-40, 10% glycerol, protease inhibitors). Cells wereto make the recombinant adenovirus using protocols described pre-
sonicated, and cell debris was removed by centrifugation. Superna-viously (He et al., 1998). ACTR-specific antibody was generated
tant (500 ml) was mixed overnight at 48C with the following dilutionsby injecting rabbits with GST-ACTR (aa 756±1027, a region poorly
of antibodies: anti-FLAG (D-8, 1:100), anti-hERa (H-184, 1:200), andconserved among the p160 coactivators) and affinity purified. Trans-
anti-p300 (N-15, 1:200) from Santa Cruz Biotech; anti-Brg1 (1:200)fection was performed essentially as described (Chen et al., 1997).
and anti-BAF155 (1:200) from Dr. Gerald Crabtree; and anti-ACTR
(aa 756±1027, 1:200). Immunoprecipitates were subjected to SDS±ChIP
PAGE and analyzed by Western blotting using anti-ERa (H-184,MCF-7 and HL-60/60(R) cells were grown in media supplemented
1:500).with 10% charcoal-dextran stripped serum for at least 3 days before
being treated with hormones (1027 M 17b-estrodiol [E2, Sigma],
4-hydroxyl tamoxifen [Sigma], or ICI182,780 [Tocris], 2 3 1027 M GST Pull-Down Assays
GST-ACTR (aa 621±728) fusion proteins (about 100 to 200 ng) onall-trans retinoic acid [Sigma] or 5 3 1028 M 1,25-[OH]2-D3 [CalBio-
chem]), respectively, for specified period of times. Approximately glutathione agarose beads were mixed with 5 ml in vitro translated
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[35S]-labeled receptors that had been preincubated with cognate Cavailles, V., Augereau, P., Garcia, M., and Rochefort, H. (1988).
Estrogens and growth factors induce the mRNA of the 52K-pro-ligands on ice for 1 hr, and indicated concentrations of peptides in
200 ml of PPI buffer (20 mM Tris [pH 8.0], 150 mM KCl, 1 mM EDTA, cathepsin-D secreted by breast cancer cells. Nucleic Acids Res. 16,
1903±1919.4 mM MgCl2, 10% glycerol, 1 mM DTT). The mixture was incubated
at 48C for 2 hr, and the beads were washed five times with PPI buffer. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima, T., Schulman,
Bound proteins were eluted in SDS sample buffer and subjected to I.G., Juguilon, H., Montminy, M., and Evans, R.M. (1996). Role of
SDS±PAGE and autoradiography. CBP/P300 in nuclear receptor signaling. Nature 383, 99±103.
Chen, K.S., and DeLuca, H.F. (1995). Cloning of the human 1
EMSA alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and
Purified GST-ACTR RID proteins were acetylated by either p300 full- identification of two vitamin D-responsive elements. Biochim. Bio-
length or p300 C-terminal fragment (aa 1135±2414) in the presence phys. Acta 1263, 1±9.
or absence of cold acetyl-CoA, as described above in the protein
Chen, H., Lin, R.J., Schiltz, R.L., Chakravarti, D., Nash, A., Nagy,acetyltransferase assays. For a 15 ml EMSA reaction, 50 to 100 ng
L., Privalsky, M.L., Nakatani, Y., and Evans, R.M. (1997). Nuclearof purified hERa (Affinity Bioreagents) was mixed with 0.5 ml of
receptor coactivator ACTR is a novel histone acetyltransferase andacetylation reaction mixture and 1 mM E2 in EMSA buffer (10 mM
forms a multimeric activation complex with P/CAF and CBP/p300.Tris [pH 7.5], 75 mM KCl, 1 mM MgCl2, 100 ng/ml Poly [dI/dC], 1 mg/
Cell 90, 569±580.ml BSA, 4% glycerol). The reaction was allowed to proceed on ice
Darimont, B.D., Wagner, R.L., Apriletti, J.W., Stallcup, M.R., Kushner,for 30 min. 32P-labeled probes (50,000 cpm) were added and incuba-
P.J., Baxter, J.D., Fletterick, R.J., and Yamamoto, K.R. (1998). Struc-tion was continued for 30 min. The reaction was resolved on a 4.5%
ture and specificity of nuclear receptor-coactivator interactions.PAGE and visualized by autoradiography.
Genes Dev. 12, 3343±3356.
Northern and Western Blot Analysis Drach, J., Zhao, S., Malavasi, F., and Mehta, K. (1993). Rapid induc-
Total RNA was prepared from MCF-7 cells using TRIZOL (GIBCO- tion of CD38 antigen on myeloid leukemia cells by all trans-retinoic
BRL). Twenty micrograms of RNA was separated and transferred acid. Biochem. Biophys. Res. Commun. 195, 545±550.
to a NYTRAN membrane. Random-labeled cDNA probes of pS2 Dubik, D., and Shiu, R.P. (1988). Transcriptional regulation of c-myc
(ATCC 57137), cathepsin D (CTD, ATCC 77556), and c-Myc (a gift oncogene expression by estrogen in hormone-responsive human
from Dr. J. M. Ruppert) were hybridized to the membranes. For breast cancer cells. J. Biol. Chem. 263, 12705±12708.
Western blotting, nuclear extracts made from 2 3 105 of MCF-7
Fondell, J.D., Ge, H., and Roeder, R.G. (1996). Ligand induction
cells were subject to SDS±PAGE. Proteins were transferred to nitro-
of a transcriptionally active thyroid hormone receptor coactivator
cellulose and probed with the following antibodies: a-ERa, complex. Proc. Natl. Acad. Sci. USA 93, 8329±8333.
a-HDAC-1 and 2 (HC-20 and C-19, Santa Cruz), a-ACTR (aa 756±
Grunstein, M. (1997). Histone acetylation in chromatin structure and1027), a-p300 (Upstate Biotech), a-Brg1 (a gift from Dr. Gerald
transcription. Nature 389, 349±352.Crabtree), and a-PCAF (a gift from Dr. Pat Nakatani).
Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific
DNA binding by acetylation of the p53 C-terminal domain. Cell 90,Acknowledgments
595±606.
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